You are here
CDC Updates Guidelines on Sexually Transmitted Disease
The agency’s revised guidelines were published in the August 10 issue of Morbidity and Mortality Weekly Report.
For the treatment of uncomplicated urogenital, anorectal, and pharyngeal gonorrhea, the CDC now recommends combination therapy with a single intramuscular dose of ceftriaxone 250 mg plus either a single dose of azithromycin 1 g orally or doxycycline 100 mg orally twice daily for 7 days.
When ceftriaxone cannot be used for the treatment of urogenital or rectal gonorrhea, two alternative options are available: 1) cefixime 400 mg orally plus either azithromycin 1 g orally or doxycycline 100 mg twice daily orally for 7 days if ceftriaxone is not readily available, or 2) azithromycin 2 g orally in a single dose if ceftriaxone cannot be given because of severe allergy.
Gonorrhea is a major cause of serious reproductive complications in women and can facilitate the transmission of human immunodeficiency virus (HIV). Effective treatment is a cornerstone of U.S. gonorrhea control efforts, the CDC says, but treatment of the disease has been complicated by the ability of Neisseria gonorrhoeae to develop antimicrobial resistance.
For more information, visit the CDC Web site.